SANSTAR2025-10-012025-12-31SANSTAR2025-12-31SANSTAR2025-04-012025-12-31SANSTAR2025-10-012025-12-31in-capmkt:OtherExpenses4MemberSANSTAR2025-04-012025-12-31in-capmkt:OtherExpenses4MemberSANSTAR2025-10-012025-12-31AuditorDomain15442172025-12-31Statement15442172025-10-012025-12-31Statement1SANSTAR2025-12-31StatementDynamic1I1Statement1SANSTAR2025-12-31StatementDynamic1I2Statement1SANSTAR2025-12-31StatementDynamic1I3Statement1iso4217:INRxbrli:pureiso4217:INRxbrli:shares544217SANSTARNOTLISTEDINE08NE01025SANSTAR LIMITEDMain BoardEquity2025-04-012026-03-312026-02-132026-02-03INRCroresQuarterlyThird quarterSingle segmentManufacturing of starch & Derivative2026-02-1317:00:002026-02-1318:00:00Declaration of unmodified opiniontrue1falseNot Applicable2025-10-012025-12-31UnauditedStandalone201760000029300000204690000013242000000-25100000588000005700000240000004808000001868400000178500000017850000041700000100000418000000136700000000013670000040000013710000036450000020.750.75000.750.751 The above financial results have been reviewed and recommended by the Audit Committee at its meeting held on February 13 2026 The Board of Directors at its meeting held on February 13 2026 have approved the above results and taken them on record <BR> <BR> 2 As the company is having only one segment Manufacture of Starch there are no reportable segments in accordance with the requirement of IND AS 108 Operating Segment specified under Section 133 of the Companies Act 2013 <BR> <BR> 3 The above financial results of the Company have been prepared in accordance with Indian Accounting Standards Ind AS notified under Section 133 of the Companies Act 2013 read with the Companies Indian Accounting Standard Rules 2015 as amended and in terms of Regulation 33 of SEBI Listing Obligations and Disclosure Requirements Regulations 2015 as amended <BR> <BR> 4 The figures for the previous period year have been regrouped reclassified wherever necessary to make them comperable <BR> <BR> 5 In Financial year 2024 2025 the Company has completed its Initial Public Offer IPO of 53700000 equity shares of face value of 2 each comprising of i fresh issue of 41800000 equity shares at an issue price of 95 per equity share ii an offer for sale of 11900000 equity shares at an issue price of 95 per equity share The equity shares of the Company were listed on BSE Limited BSE and National Stock Exchange of India Limited NSE on July 26 2024 <BR> <BR> Details of the utilisation of IPO net proceeds is summarised below: Rs In Crore <BR> Particulars Objects of the issue as per offer document Utilised upto December 31 2025 Unutilised as on December 31 2025 <BR> Capital expenditure for expansion of dhule plant 181.56 177.25 4.31 <BR> Borrowing Repayment 100.00 100.00 - <BR> General Corporate purposes 79.98 79.98 - <BR> Total Utilisation of funds 361.54 357.23 4.31 <BR> <BR> Out of the Net proceeds which were unutilised as at December 31, 2025, 4.31 Crore are temporarily invested in Fixed Deposits. <BR> <BR> 2025-04-012025-12-31UnauditedStandalone567850000085500000576400000040836000000-22200000166200000172000007140000012678000005584000000180000000018000000041000000-6000004040000001396000000000139600000013960000036450000020.770.77000.770.77Other Expenses480800000Other Expenses1267800000-40000004000000UnauditedfalseS C BAPNA & ASSOCIATEStrue2028-12-31Public Issues2024-07-2439710000002025-12-31trueACUITE RATINGS AND RESEARCH LIMITEDfalseFagun ShahCompany Secretary and Compliance OfficerAhmedabad2026-02-13Funding the capital expenditure requirement for expansion of our Dhule facilityNone1815600000017725000000The company has utilized INR 177.249 Crores towards this objectRepayment and / or pre-payment, in part of full, of certain borrowing availed by our companyNone1000000000010000000000The company has fully utilized INR 100.000 Crores towards this objectGeneral Corporate PurposesNone81930000008193000000The company has fully utilized INR 81.929 Crores towards this object. This includes INR 1.950 Crores spent towards Issue Related Expenses